The hospital head must ensure adequate supply of drugs for treatment.

The Drug Administration of Vietnam has received a notice from the manufacturer about the possibility of a temporary shortage of Concerta expected for 3 months; war in some areas may disrupt the supply of blood products and blood products, opioid pain relievers...

According to the Drug Administration of Vietnam ( Ministry of Health ), recently, some situations and developments in the world and in the country have affected the supply of drugs such as: Infectious diseases are increasing; wars in some countries and regions in the world can disrupt the supply of blood products and blood products, opioid pain relievers; foreign drug suppliers no longer continue to supply drugs with circulation registration certificates; radioactive drug manufacturing facilities have changed their operations...

The Drug Administration of Vietnam has just received a notice from Johnson & Johnson Company Limited (Vietnam) about the possibility of a temporary shortage of Concerta (Methylphenidate hydrochloride 36mg) - a drug to treat attention deficit hyperactivity disorder (ADHD) - in the Vietnamese market for 3 months.

The head of the hospital is responsible for ensuring adequate supply of quality drugs for emergency and treatment purposes.

Faced with this situation, the Drug Administration of Vietnam has issued an official dispatch requesting the Department of Health of provinces and centrally-run cities to direct hospitals, disease control centers and medical facilities in the area to develop plans and implement drug procurement to ensure adequate supply of drugs, absolutely not allowing shortages or shortages of drugs to serve the examination and treatment of people.

At the same time, ensure quality and reasonable prices, avoid sudden price increases, focus on ensuring adequate supply of drugs for emergency work; disease prevention drugs, blood products and blood products, opioid-based analgesic products.

In case of necessity, hospitals proactively seek drug supply sources, carry out imports in accordance with the law and seek alternative treatment measures.

The head of a medical examination and treatment facility is responsible for ensuring adequate supply of quality drugs to meet the needs of emergency, medical examination and treatment at the medical examination and treatment facility.

Direct local pharmaceutical businesses to increase supply, develop and implement drug supply plans to serve people's medical examination and treatment needs.

Regarding drugs containing the active ingredient Methylphenidate hydrochloride, according to data searched at https://dichvucong.dav.gov.vn/congbothuoc/index, there are currently 6 drugs containing this active ingredient that have been granted a valid circulation registration certificate in Vietnam.

To ensure adequate supply of drugs for medical examination and treatment needs, the Drug Administration of Vietnam requests Johnson & Johnson Company Limited (Vietnam) to coordinate with the manufacturer to increase production activities to ensure the supply of Concerta, and develop and implement a drug supply plan to meet medical treatment needs.

The Department of Health of provinces and centrally run cities directs drug trading and importing establishments in the area to contact drug manufacturing establishments containing the active ingredient Methylphenidate hydrochloride to find alternative drugs, and have a plan to fully and promptly supply drugs for treatment needs.

Medical examination and treatment facilities in the area and hospitals and institutes with beds under the Ministry of Health proactively and promptly contact importing and supplying units to sign contracts, bid, and purchase (including proactive measures to replace drugs when the current supply is in short supply) to ensure timely availability of drugs for treatment needs.

Source: https://cand.com.vn/y-te/nguoi-dung-dau-benh-vien-phai-bao-dam-cung-ung-du-thuoc-cho-dieu-tri-i774486/